CLINICAL_TRIALS
trial_result
· 2013-01-31
Clinical Trial Update: Use of Infliximab for the Treatment of Pemphigus Vulgaris [Phase 2]
Summary
Phase 2 trial results evaluating infliximab for Pemphigus vulgaris have been completed and posted. The study was sponsored by NIAID and results were posted on 2…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Pemphigus | Phase 2 | Status: COMPLETED | Results posted: 2013-01-31